78 results
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
7 May 24
Rhythm Pharmaceuticals Rhythm Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Update
7:10am
of therapy (N=18), and preliminary data from Rhythm’s long-term extension study showing setmelanotide achieved mean BMI reduction of approximately 26% at one … asset
Intangible assets, net
Restricted cash
Other long-term assets
Total assets
Liabilities and stockholders’ equity
Current liabilities:
Accounts
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
22 Feb 24
Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update
7:01am
assets
Property and equipment, net
Right-of-use asset
Intangible assets, net
Restricted cash
Other long-term assets
Total assets
Liabilities … liabilities
Long-term liabilities:
Other long-term liabilities
Lease liability
Derivative liability
Total liabilities
Stockholders’ equity:
Preferred Stock
8-K
EX-99.1
gwivesolxq2t6jr4
7 Nov 23
Rhythm Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Update
7:05am
8-K
EX-99.1
vgmfdghwm 8itz4
1 Aug 23
Rhythm Pharmaceuticals Reports Second Quarter 2023 Financial Results and Business
7:05am
8-K
EX-99.1
eve95fh5lioqno 1fy
2 May 23
Rhythm Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Update
7:05am
8-K
EX-99.1
j121bczu
8 Nov 22
Rhythm Pharmaceuticals Reports Third Quarter 2022 Financial Results and Business Update
7:03am
8-K
EX-1.1
2ot 9ntnh84zbmm
15 Sep 22
Other Events
4:02pm
424B5
g3h57
15 Sep 22
Prospectus supplement for primary offering
4:00pm
424B5
6awxkdz92
14 Sep 22
Prospectus supplement for primary offering
4:05pm
8-K
EX-99.1
924n7tyc
2 Aug 22
Rhythm Pharmaceuticals Reports Second Quarter 2022 Financial Results and Business Update
7:02am